We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+20.94%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$612B
AUM Growth
+$90.2B
Cap. Flow
-$9.31B
Cap. Flow %
-1.52%
Top 10 Hldgs %
32.09%
Holding
12,204
New
1,722
Increased
4,580
Reduced
4,534
Closed
1,264

Top Sells

Rank Stock Value
1
C icon
Citigroup
C
+$703M
2
BAC icon
Bank of America
BAC
+$690M
3
AMZN icon
Amazon
AMZN
+$678M
4
JPM icon
JPMorgan Chase
JPM
+$601M
5
META icon
Meta Platforms (Facebook)
META
+$431M

Sector Composition

Rank Sector Weight
1 Technology 2.38%
2 Consumer Discretionary 1.48%
3 Healthcare 0.92%
4 Communication Services 0.78%
5 Financials 0.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GMLP
10751
CALL
DELISTED
Golar LNG Partners LP
GMLP
$35K ﹤0.01%
13,600
+2,800
+26% +$6.66K
BNGO icon
10752
Bionano Genomics
BNGO
$14.3M
$34K ﹤0.01%
+18
New +$6.73K
SLNO
10753
PUT
DELISTED
Soleno Therapeutics
SLNO
$34K ﹤0.01%
1,180
-147
-11% -$4.24K
SONN
10754
DELISTED
Sonnet BioTherapeutics
SONN
$34K ﹤0.01%
+6
New +$38.1K
STR
10755
DELISTED
Sitio Royalties
STR
$34K ﹤0.01%
2,672
-590
-18% -$5.99K
TLSA icon
10756
Tiziana Life Sciences
TLSA
$139M
$34K ﹤0.01%
+16,664
New +$52.7K
LEJU
10757
PUT
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$34K ﹤0.01%
+1,500
New +$35.3K
GLMD icon
10758
Galmed Pharmaceuticals
GLMD
$4.51M
$33K ﹤0.01%
+7
New +$35K
MRKR icon
10759
CALL
Marker Therapeutics
MRKR
$24.2M
$33K ﹤0.01%
2,270
-810
-26% -$12.6K
MVO
10760
DELISTED
MV Oil Trust
MVO
$33K ﹤0.01%
+10,696
New +$29.5K
SOS
10761
SOS Limited
SOS
$16.7M
$33K ﹤0.01%
+30
New +$45.5K
QNTM
10762
PUT
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$129
$33K ﹤0.01%
320
+102
+47% +$12K
NNA
10763
DELISTED
Navios Maritime Acquisition Corporation
NNA
$33K ﹤0.01%
+10,718
New +$41.3K
DHF
10764
BNY Mellon High Yield Strategies Fund
DHF
$172M
$32K ﹤0.01%
+10,566
New +$30.2K
PHIO icon
10765
Phio Pharmaceuticals
PHIO
$13.9M
$32K ﹤0.01%
+112
New +$28.3K
SYBX
10766
DELISTED
Synlogic
SYBX
$32K ﹤0.01%
+987
New +$31.5K
WTI icon
10767
CALL
W&T Offshore
WTI
$539M
$32K ﹤0.01%
14,600
-20,400
-58% -$39.3K
TYME
10768
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$32K ﹤0.01%
26,307
-7,449
-22% -$7.62K
LSTA icon
10769
Lisata Therapeutics
LSTA
$16.3M
$31K ﹤0.01%
1,446
-2,779
-66% -$66K
IMDX
10770
PUT
Insight Molecular Diagnostics
IMDX
$141M
$31K ﹤0.01%
+655
New +$24K
STGW icon
10771
PUT
Stagwell
STGW
$2.11B
$31K ﹤0.01%
+12,400
New +$27.7K
TLSA icon
10772
PUT
Tiziana Life Sciences
TLSA
$139M
$31K ﹤0.01%
+15,400
New +$48.7K
VIRX
10773
PUT
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$31K ﹤0.01%
4,486
-1,600
-26% -$8.35K
BSQR
10774
DELISTED
BSQUARE Corporation
BSQR
$31K ﹤0.01%
+20,427
New +$27.1K
DCOY
10775
Decoy Therapeutics
DCOY
$1.97M
$30K ﹤0.01%
+1
New +$29.3K

Similar funds

Jeff Yass's Q4 2020 Portfolio in Review

As of Q4 2020, Jeff Yass held 12,204 positions worth $612B, up 17% from $522B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q4 2020 filing shows 1,722 new, 4,580 increased, 4,534 reduced and 1,264 closed positions. Its largest new stake was International Flavors & Fragrances: 726,729 shares worth $79.1M. The largest sale was Citigroup, an estimated $703M.

By sector, the portfolio is most concentrated in Technology at 2.4% of assets, up from 2% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Jeff Yass's largest Q4 2020 buy was International Flavors & Fragrances: 726,729 shares worth $79.1M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $1.46B increase.
  • Jeff Yass's biggest Q4 2020 reduction was Citigroup, cutting an estimated $703M.
  • Jeff Yass fully exited Vanguard Total International Bond ETF in Q4 2020, selling an estimated $146M.
  • Jeff Yass's ten largest holdings make up 32% of its $612B portfolio in Q4 2020.
  • Jeff Yass opened 1,722 new positions and closed 1,264 in Q4 2020.
  • Jeff Yass's portfolio value rose 17% quarter-over-quarter to $612B.

Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.